Nurse Practitioner Program year 2023 Reported 2021–2023 Source: CMS Open Payments, 2026 publication

Jason Hamrick

Nurse Practitioner, Psychiatric/Mental Health Chattanooga, TN Nurse Practitioner

NPI 1669095907 CMS profile 10553164

6110 Shallowford Rd, Chattanooga, TN 37421

Open in the dashboard

General payments

$17,019

131 records reported · program years 2021–2023

Research payments

$0

Paid to them · None reported · program years 2021–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Jason Hamrick of Chattanooga, TN is reported in the CMS Open Payments database as having received $17,019 across 131 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $46 2
2022 General $13,882 90
2021 General $3,091 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Hamrick
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Jason Hamrick were reported at $0. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Jason Hamrick Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $3,091 $166 $54–$482 $132
2022 $13,882 $195 $66–$559 $149
2023 $46 $233 $82–$673 $160
2024 $0 $236 $84–$688 $164
2025 $0 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2023
  1. Teva Pharmaceuticals USA, Inc. $14,231 44 payments
  2. Alkermes, Inc. $874 23 payments
  3. ITI, Inc. $558 12 payments
  4. Janssen Pharmaceuticals, Inc $478 19 payments
  5. Otsuka America Pharmaceutical, Inc. $243 9 payments
  6. AbbVie, Inc. $228 9 payments
  7. Neurocrine Biosciences, Inc. $163 4 payments
  8. Supernus Pharmaceuticals, Inc. $117 4 payments
  9. Lundbeck LLC $58 3 payments
  10. Indivior Inc. $23 1 payment
  11. Other $45 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,100 10 payments
  2. Food and Beverage $4,130 111 payments
  3. Travel and Lodging $742 9 payments
  4. Education $47 1 payment
Products named General payments · program years 2021–2023
  1. AUSTEDO $12,431 43 payments
  2. CAPLYTA $558 12 payments
  3. LYBALVI Cns $480 15 payments
  4. LYBALVI Cns $455 14 payments
  5. ARISTADA Cns $391 14 payments
  6. ARISTADA Cns $391 14 payments
  7. ARISTADA INITIO $366 13 payments
  8. LYBALVI Cns $333 6 payments
  9. LYBALVI Cns $333 6 payments
  10. INVEGA TRINZA $289 11 payments
  11. Other $2,057 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 3 billing codes

Paid by Medicare

$673

Medicare's payments for the services billed

Medicare patients

13

Average age 52

Services billed

15

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Heart failure 0%
Ischemic heart disease 0%
Atrial fibrillation 0%
Cancer 0%
Osteoporosis 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

131 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Psychiatric/Mental Health in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record